Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
For the development of a collection of tumor explant models from patients who developed acquired resistance to targeted therapies following initial responses
To apply Insilico’s technology for predictive biomanufacturing to create & execute more efficient production processes of Teva’s biopharmaceutical therapeutics
Cognate will serve as a technology reference partner for Astero's AT6 Cell Thawing Platform allowing Cognate's clients to evaluate and control thaw cycles